Almujtama Alraida Medical Co. (9592) is listed on Nomu of the Saudi Exchange (Tadawul) under sector Consumer Staples Distribution & Retail. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).

For fiscal year 2025, Almujtama Alraida Medical Co. reported revenue of SAR 455M, net profit of SAR 8M, and earnings per share of SAR 0.88. Total assets stood at SAR 515M with total equity of SAR 146M and total liabilities of SAR 369M.

Operating cash flow for 2025 was SAR 25M, representing a cash conversion ratio of 2.98 relative to net profit. Free cash flow was SAR 2M.

Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2025, SAR 2.98 arrived as operating cash. This indicates Exceptional quality earnings based on the cash conversion ratio of 2.98.

Revenue growth from 2024 to 2025: +5.6%. Net profit growth over the same period: +5.8%. 3-year revenue CAGR: 7.4%. 3-year net profit CAGR: -23.9%.

Key financial ratios for 2025: Return on Equity 5.7%, Return on Assets 1.6%, Net Margin 1.9%, Debt to Equity 2.52.

In 2024, Almujtama Alraida Medical Co. reported revenue of SAR 431M and net profit of SAR 8M, compared to SAR 455M and SAR 8M respectively in 2025.